Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Enzymatically in situ shell cross-linked micelles composed of 4-arm PPO-PEO and heparin for controlled dual drug delivery.

Kim BY, Bae JW, Park KD.

J Control Release. 2013 Dec 10;172(2):535-40. doi: 10.1016/j.jconrel.2013.05.003. Epub 2013 May 13.

PMID:
23680287
2.

Controlled dual release of basic fibroblast growth factor and indomethacin from heparin-conjugated polymeric micelle.

Lee JS, Bae JW, Joung YK, Lee SJ, Han DK, Park KD.

Int J Pharm. 2008 Jan 4;346(1-2):57-63. Epub 2007 Jun 22.

PMID:
17689210
3.

Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor.

Lee JS, Go DH, Bae JW, Lee SJ, Park KD.

J Control Release. 2007 Feb 12;117(2):204-9. Epub 2006 Nov 15.

PMID:
17196698
4.

In situ forming hydrogels based on tyramine conjugated 4-Arm-PPO-PEO via enzymatic oxidative reaction.

Park KM, Shin YM, Joung YK, Shin H, Park KD.

Biomacromolecules. 2010 Mar 8;11(3):706-12. doi: 10.1021/bm9012875.

PMID:
20121075
6.
7.

Injectable and mechanically robust 4-arm PPO-PEO/graphene oxide composite hydrogels for biomedical applications.

Lee Y, Bae JW, Hoang Thi TT, Park KM, Park KD.

Chem Commun (Camb). 2015 May 25;51(42):8876-9. doi: 10.1039/c5cc02511g.

PMID:
25925723
8.

Synthesis and characterizations of in situ cross-linkable gelatin and 4-arm-PPO-PEO hybrid hydrogels via enzymatic reaction for tissue regenerative medicine.

Park KM, Lee Y, Son JY, Oh DH, Lee JS, Park KD.

Biomacromolecules. 2012 Mar 12;13(3):604-11. doi: 10.1021/bm201712z. Epub 2012 Feb 8.

PMID:
22263670
9.

Stabilized mixed micelles with a temperature-responsive core and a functional shell.

Petrov P, Tsvetanov CB, Jérôme R.

J Phys Chem B. 2009 May 28;113(21):7527-33. doi: 10.1021/jp901307d.

PMID:
19405518
10.

Dissipative particle dynamics simulation on paclitaxel loaded PEO-PPO-PEO block copolymer micelles.

Wang Z, Jiang J.

J Nanosci Nanotechnol. 2014 Mar;14(3):2644-7.

PMID:
24745277
11.

Effect of cross-linking on the performance of micelles as drug delivery carriers: a cell uptake study.

Kim Y, Pourgholami MH, Morris DL, Stenzel MH.

Biomacromolecules. 2012 Mar 12;13(3):814-25. doi: 10.1021/bm201730p. Epub 2012 Feb 27.

PMID:
22276949
12.

Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.

Cai S, Liu Y, Zheng Shu X, Prestwich GD.

Biomaterials. 2005 Oct;26(30):6054-67. Epub 2005 Apr 22.

PMID:
15958243
13.

Nonionic polymeric micelles for oral gene delivery in vivo.

Chang SF, Chang HY, Tong YC, Chen SH, Hsaio FC, Lu SC, Liaw J.

Hum Gene Ther. 2004 May;15(5):481-93.

PMID:
15144578
15.
16.
17.

Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.

Jeon O, Kang SW, Lim HW, Hyung Chung J, Kim BS.

Biomaterials. 2006 Mar;27(8):1598-607. Epub 2005 Sep 16.

PMID:
16146647
18.

PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy.

Alvarez-Lorenzo C, Sosnik A, Concheiro A.

Curr Drug Targets. 2011 Jul 1;12(8):1112-30. Review.

PMID:
21443477

Supplemental Content

Support Center